/GENSF
GENSF Stock - Genus plc
Healthcare|BiotechnologyOTC
$35.15+0.00%
+$0.00 (+0.00%) • Dec 19
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.72
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.89
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $38.66
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GENSF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$34.80 – $35.50
TARGET (TP)$40.42
STOP LOSS$32.34
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.77
52W High$35.15
52W Low$21.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $672.80M | $668.80M | $689.70M | $593.40M | $574.30M |
| Gross Profit | $672.80M | $178.70M | $239.30M | $226.00M | $232.20M |
| Gross Margin | 100.0% | 26.7% | 34.7% | 38.1% | 40.4% |
| Operating Income | $42.40M | $6.40M | $40.50M | $56.60M | $61.50M |
| Net Income | $19.30M | $7.90M | $33.30M | $40.90M | $47.30M |
| Net Margin | 2.9% | 1.2% | 4.8% | 6.9% | 8.2% |
| EPS | $0.25 | $0.12 | $0.51 | $0.63 | $0.73 |
Company Overview
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
GENSFBeat Rate
0%
Last 2 quarters
Avg Surprise
-39.8%
EPS vs Estimate
Beats / Misses
0/2
Last 12 quarters
Latest EPS
$0.36
Q3 2025
EPS Surprise History
Q4 21
No data
Q2 22
No data
Q4 22
No data
Q2 23
No data
Q1 24
-69.2%
$0.13vs$0.42
Q2 24
No data
Q1 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 25, 2026 | — | — | — | — |
Q3 2025 | Sep 4, 2025 | — | $0.36 | — | — |
Q1 2025 | Feb 27, 2025 | — | $0.03 | — | — |
Q3 2024 | Sep 5, 2024 | — | — | — | — |
Q2 2024 | Jun 30, 2024 | — | $-0.05 | — | — |
Q2 2024 | Apr 30, 2024 | — | — | — | — |
Q1 2024 | Feb 22, 2024 | $0.42 | $0.13 | -69.2% | ✗ MISS |
Q3 2023 | Sep 7, 2023 | — | — | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.38 | — | — |
Q4 2022 | Dec 30, 2022 | — | $0.25 | — | — |
Q3 2022 | Sep 8, 2022 | — | — | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.39 | — | — |
Q4 2021 | Dec 30, 2021 | — | $0.41 | — | — |
Q3 2021 | Sep 9, 2021 | — | — | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.33 | — | — |
Q4 2020 | Dec 30, 2020 | — | $0.65 | — | — |
Q3 2020 | Sep 8, 2020 | $0.52 | — | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.32 | — | — |
Q4 2019 | Dec 30, 2019 | $0.52 | $0.46 | -10.3% | ✗ MISS |
Q2 2019 | Jun 30, 2019 | — | $0.29 | — | — |
Latest News
Loading news...
Frequently Asked Questions about GENSF
What is GENSF's current stock price?
Genus plc (GENSF) is currently trading at $35.15 per share. The stock has moved +0.00% today.
What is the analyst price target for GENSF?
No analyst price targets are currently available for this stock.
What sector is Genus plc in?
Genus plc operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is GENSF's market cap?
Genus plc has a market capitalization of $2.32 billion, making it a mid-cap company.
Does GENSF pay dividends?
No, Genus plc does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBOEUF
Bonesupport Holding AB (publ)
$18.57
Mkt Cap: $1.2B
BRCTF
BioArctic AB (publ)
$34.62
Mkt Cap: $3.1B
CSPHF
CStone Pharmaceuticals
$0.89
Mkt Cap: $1.3B
GRRMF
Gerresheimer AG
$51.41
Mkt Cap: $1.8B
GTBIF
Green Thumb Industries Inc.
$8.15
Mkt Cap: $1.9B
MEOBF
Mesoblast Limited
$1.35
Mkt Cap: $1.7B
NURPF
Neuren Pharmaceuticals Limited
$12.88
Mkt Cap: $1.6B
ONTTF
Oxford Nanopore Technologies plc
$1.72
Mkt Cap: $1.7B
PHMMF
Pharma Mar, S.A.
$86.26
Mkt Cap: $1.5B
PPTDF
PeptiDream Inc.
$12.80
Mkt Cap: $1.7B
Explore stocks similar to GENSF for comparison